Climb Bio (CLYM) Profit After Tax (2020 - 2026)
Climb Bio (CLYM) posted Profit After Tax of -$14.0 million for Q1 2026, up 20.07% on a QoQ basis from -$17.5 million in Q4 2025, and up 32.63% year-over-year from -$10.6 million in Q1 2025.
Climb Bio (CLYM) Profit After Tax (2020 - 2026) Analysis & Trends
Climb Bio's Profit After Tax history runs 7 years deep, the most recent figure standing at -$14.0 million for Q1 2026.
- Quarterly Profit After Tax rose 32.63% year-over-year to -$14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$53.1 million (up 42.93% YoY) and the FY2025 annual result came in at -$59.9 million, up 19.01% from the prior year.
- Profit After Tax was -$14.0 million for Q1 2026 at Climb Bio, up from -$17.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$1.7 million in Q1 2024 and bottomed at -$54.9 million in Q2 2024.
- A 5-year average of -$13.4 million and a median of -$9.7 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax soared 92.39% — and 2025, when it plunged 1124.57%.
- Climb Bio's Profit After Tax stood at -$7.5 million in 2022, then soared by 51.82% to -$3.6 million in 2023, then tumbled by 137.31% to -$8.6 million in 2024, then slumped by 103.23% to -$17.5 million in 2025, then increased by 20.07% to -$14.0 million in 2026.
- Business Quant data shows CLYM's Profit After Tax at -$14.0 million in Q1 2026, -$17.5 million in Q4 2025, and -$12.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | -14.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.00 Mn |
| Dec 31, 2025 | -17.52 Mn |
| Sep 30, 2025 | -12.89 Mn |
| Jun 30, 2025 | -8.67 Mn |
| Mar 31, 2025 | -20.78 Mn |
| Dec 31, 2024 | -8.62 Mn |
| Sep 30, 2024 | -8.69 Mn |
| Jun 30, 2024 | -54.89 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Dec 31, 2023 | -3.63 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | -5.22 Mn |
| Mar 31, 2023 | -22.29 Mn |
| Dec 31, 2022 | -7.54 Mn |
| Sep 30, 2022 | -9.68 Mn |
| Jun 30, 2022 | -14.60 Mn |
| Mar 31, 2022 | -13.60 Mn |
| Dec 31, 2021 | -10.67 Mn |
| Sep 30, 2021 | -9.62 Mn |
| Jun 30, 2021 | -8.72 Mn |